FDA alerts clinicians about fake Botox

Unapproved versions of onabotulinumtoxinA (Botox, Allergan) sent by foreign suppliers has prompted the Food and Drug Administration to issue alerts to more than 350 medical practices that may have purchased the products.
Source: Modern Medicine - Category: Journals (General) Source Type: news